Anna L. Gloyn mainly focuses on Internal medicine, Endocrinology, Genetics, Type 2 diabetes and Diabetes mellitus. Her Internal medicine research is multidisciplinary, relying on both Mutation and Permanent neonatal diabetes mellitus. Her research in Genetics intersects with topics in Glucose homeostasis and Islet.
Her Type 2 diabetes research is multidisciplinary, incorporating perspectives in Exon, Cancer research, Allele and Insulin resistance. As part of one scientific family, Anna L. Gloyn deals mainly with the area of Diabetes mellitus, narrowing it down to issues related to the Single-nucleotide polymorphism, and often GLUT2, Immunohistochemistry, Adipose tissue and Glucose transporter. Her Genome-wide association study research incorporates elements of SNP, Genetic association, Locus, Imputation and Genetic architecture.
Anna L. Gloyn mainly investigates Internal medicine, Endocrinology, Genetics, Type 2 diabetes and Diabetes mellitus. Her Internal medicine study often links to related topics such as Haploinsufficiency. The concepts of her Endocrinology study are interwoven with issues in Mutation and Permanent neonatal diabetes mellitus.
In her work, Chromatin and Expression quantitative trait loci is strongly intertwined with Islet, which is a subfield of Genetics. Her Type 2 diabetes research includes elements of Adipose tissue, Genotype and Bioinformatics. Her Diabetes mellitus research focuses on Allele and how it relates to Proinsulin and Locus.
Anna L. Gloyn focuses on Genome-wide association study, Computational biology, Epigenomics, Type 2 diabetes and HNF1A. Her Genome-wide association study study necessitates a more in-depth grasp of Genetics. Anna L. Gloyn interconnects Chromatin, Precision medicine and Transcriptome in the investigation of issues within Computational biology.
Her Type 2 diabetes study integrates concerns from other disciplines, such as Pancreatic islets, Internal medicine, Bioinformatics and Glucose homeostasis. Anna L. Gloyn is studying Insulin, which is a component of Internal medicine. Her HNF1A study also includes
Her scientific interests lie mostly in Genome-wide association study, Genetic association, Allele, Computational biology and Genetics. Her studies deal with areas such as Precision medicine, Medical physics, Epidemiology and Genomics as well as Genome-wide association study. Her Genetic association research is multidisciplinary, incorporating elements of Epigenomics, Induced pluripotent stem cell and Effector.
Her studies in Allele integrate themes in fields like Diabetes mellitus, Endocrinology, Proband, Zinc Transporter 8 and Immunology. She studies Diabetes mellitus, namely HNF1A. Her Genetics study frequently intersects with other fields, such as Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Josée Dupuis;Josée Dupuis;Claudia Langenberg;Inga Prokopenko;Richa Saxena;Richa Saxena.
Nature Genetics (2010)
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (vol 42, pg 105, 2010)
J Dupuis;C Langenberg;I Prokopenko;R Saxena.
Nature Genetics (2010)
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
Benjamin F. Voight;Benjamin F. Voight;Laura J. Scott;Valgerdur Steinthorsdottir;Andrew P. Morris.
Nature Genetics (2010)
A genome-wide association search for type 2 diabetes genes in African Americans.
N D Palmer;C W McDonough;P J Hicks;B H Roh.
PLOS ONE (2012)
Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
Anna L Gloyn;Ewan R. Pearson;Jennifer F. Antcliff;Peter Proks.
The New England Journal of Medicine (2004)
Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes
Anna L. Gloyn;Michael N. Weedon;Katharine R. Owen;Martina J. Turner.
The genetic architecture of type 2 diabetes
Christian Fuchsberger;Christian Fuchsberger;Jason A. Flannick;Jason A. Flannick;Tanya M. Teslovich;Anubha Mahajan.
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
Anubha Mahajan;Daniel Taliun;Matthias Thurner;Neil R. Robertson.
Nature Genetics (2018)
Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals
Z Dastani;Hivert M-F.;Hivert M-F.;N Timpson;Perry Jrb.;Perry Jrb..
PLOS Genetics (2012)
Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Kara K. Osbak;Kevin Colclough;Cecile Saint-Martin;Nicola L. Beer.
Human Mutation (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: